Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



LAPOINTE ANTHONY GREGG Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2023 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Granted 25,000 shares @ $0
Granted 30,000 options to buy @ $1.32, valued at $39.6k
11/21/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/21/2022 4/A LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on Astria Therapeutics, Inc.
Txns: Granted 8,333 options to buy @ $0
06/09/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/23/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/24/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2021 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC
Txns: Granted 100,000 options to buy @ $2.04, valued at $204k
05/21/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/18/2020 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SOLIGENIX, INC.
Txns: Granted 15,228 options to buy @ $1.97, valued at $30k
06/12/2020 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC
Txns: Granted 7,500 options to buy @ $6.17, valued at $46.3k
05/15/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/10/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/24/2019 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Granted 55,000 options to buy @ $2.02, valued at $111.1k
02/15/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/04/2019 4/A LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC
Txns: Granted 2,800 options to buy @ $0
01/04/2019 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on CATABASIS PHARMACEUTICALS INC
Txns: Granted 2,800 options to buy @ $4.9, valued at $13.7k
01/04/2019 3 LAPOINTE ANTHONY GREGG (Director) has filed a Form 3 on CATABASIS PHARMACEUTICALS INC
09/28/2018 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/18/2018 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Granted 30,000 options to buy @ $3.98, valued at $119.4k
11/02/2017 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on RIGEL PHARMACEUTICALS INC
Txns: Granted 80,000 options to buy @ $3.8, valued at $304k
11/02/2017 3 LAPOINTE ANTHONY GREGG (Director) has filed a Form 3 on RIGEL PHARMACEUTICALS INC
10/16/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/12/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/09/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
05/24/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
04/03/2017 3 Form 3 - Initial statement of beneficial ownership of securities
10/26/2016 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on Raptor Pharmaceutical Corp
Txns: Unknown transaction of 2,092 shares @ $9, valued at $18.8k
Disposed/sold 8,330 shares @ $9, valued at $75k
Disposed/sold 7,915 options to buy @ $5.22, valued at $41.3k
06/27/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
06/21/2016 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on ImmunoCellular Therapeutics, Ltd.
Txns: Granted 156,750 options to buy @ $0.24, valued at $37.6k
06/20/2016 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SOLIGENIX, INC.
Txns: Granted 40,541 options to buy @ $0.74, valued at $30k
06/13/2016 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC
Txns: Granted 30,000 options to buy @ $13.995, valued at $419.9k
04/19/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
10/01/2013 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SOLIGENIX, INC.
Txns: Granted 13,275 options to buy @ $2.26, valued at $30k
06/28/2013 4 LAPOINTE ANTHONY GREGG (Director) has filed a Form 4 on SCICLONE PHARMACEUTICALS INC
Txns: Granted 30,000 options to buy @ $5.13, valued at $153.9k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy